Back to User profile » Dr Xi-Jing Wang

Papers published by Dr Xi-Jing Wang:


Distinct role of the Fas rs1800682 and FasL rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese women

Wang M, Wang Z, Wang XJ, Jin TB, Dai ZM, Kang HF, Guan HT, Ma XB, Liu XH, Dai ZJ

Drug Design, Development and Therapy 2016, 10:2359-2367

Published Date: 25 July 2016

PSCA rs2294008 C > T polymorphism contributes to gastric and bladder cancer risk

Wang M, Wang XJ, Ma YF, Ma XB, Dai ZM, Lv Y, Lin S, Liu XH, Yang PT, Dai ZJ

Therapeutics and Clinical Risk Management 2015, 11:237-245

Published Date: 13 February 2015

Association between MDM2 rs 2279744 polymorphism and breast cancer susceptibility: a meta-analysis based on 9,788 cases and 11,195 controls

Gao J, Kang AJ, Lin S, Dai ZJ, Zhang SQ, Liu D, Zhao Y, Yang PT, Wang M, Wang XJ

Therapeutics and Clinical Risk Management 2014, 10:269-277

Published Date: 15 April 2014